Vonoprazan versus lansoprazole in the treatment of artificial gastric ulcers after endoscopic submucossal dissection: a randomized, open-label trial

BACKGROUND: Vonoprazan is more potent and longer acting than traditional proton pump inhibitor. Although vonoprazan is expected to be superior to proton pump inhibitor, its efficacy in the treatment of gastric ulcers following endoscopic submucosal dissection (ESD) is not fully understood. The aim o...

Descripción completa

Detalles Bibliográficos
Autores principales: Kawai, Daisuke, Takenaka, Ryuta, Ishiguro, Mikako, Okanoue, Shotaro, Gotoda, Tatsuhiro, Kono, Yoshiyasu, Takemoto, Koji, Tsugeno, Hirofumi, Fujiki, Shigeatsu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8141195/
https://www.ncbi.nlm.nih.gov/pubmed/34022796
http://dx.doi.org/10.1186/s12876-021-01822-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8141195/
https://www.ncbi.nlm.nih.gov/pubmed/34022796
http://dx.doi.org/10.1186/s12876-021-01822-5

Ejemplares similares